By Erin S. Tomiyama, OD, PhD Release Date: January 15, 2023 Expiration Date: January 15, 2026 Estimated Time to Complete Activity: 2 hours Access the...
March 21, 2023 BERLIN, Germany — Professor Dr. Jens Ellrich has been named the new Chief Scientific Officer at Dopavision, a clinical-stage...
March 17, 2023 SAN RAMON, Calif. — During the first official day of Vision Expo East 2023, CooperVision introduced the myopia-focused campaign:...
March 15, 2023 NEW YORK — On Wednesday, March 15, Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO,...
March 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Researchers from Taiwan analyzed the changes in visual function when progressive...
March 15, 2023 By Jeffrey Cooper, MS, OD If you are providing myopia management, it seems logical that you pay attention for...
March 15, 2023 By Brianna Rhue, OD, FAAO, FSLS We need better involvement from all health care professionals to reach as many...
March 15, 2023 By Matthew J. Martin, OD, FIAOMC Subjective A 12-year-old female Asian patient “WG” was referred to our office by...
March 13, 2023 GRAND RAPIDS, Mich. — Art Optical‘s orthokeratology lens system, MOONLENS, now has a new identification system. A unique set...
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
March 1, 2023 By Kate A. McClure, OD, MS, FAAO Parents who are skeptical of myopia management therapies often lack understanding and...
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In virtually every survey conducted in recent years, most eye care...
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
March 1, 2023 By Vittorio Mena OD, MS Subjective Two children, accompanied by their parents, presented at my clinic for comprehensive eye...
March 1, 2023 By Ornella Koumbo, PhD, Brien Holden Vision Institute Optical interventions that introduce myopic defocus at the peripheral retina have...
February 22, 2023 [Click here to listen to this interview.] The new chair of the 2023 board of directors of GMAC (the...
February 21, 2023 NEW YORK — Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, and Lisa McAlister, Global...
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...
sponsored content February 15, 2023 By Zachary Holland, OD, FSLS Despite the many difficulties created during the last few years, I have...
February 15, 2023 By Jagrut Lallu, BOptom, MSc In 2009, most optometrists and ophthalmologists were not open to myopia management despite growing...
February 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In this editorial, Bullimore and Brennan explore a vexing research question:...
February 15, 2023 By Michael Lipson, OD, FAAO, FSLS; Jackson Lau, OD, FAAO, FSLS; and Craig Norman, FCLSA Modern orthokeratology (OrthoK) is...
February 15, 2023 By Jeffrey Cooper, MS, OD If you identify and treat problems associated with myopia, you must assess and provide...
February 13, 2023 ST. LOUIS, Mo. — The Global Myopia Awareness Coalition (GMAC) announced its 2023 Board of Directors, including a new...
February 1, 2023 ST. LOUIS — The World Council of Optometry has announced that more than 27,500 eye care professionals and 63 global eye...
February 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Among the interventions currently available to manage childhood myopia, low-concentration atropine,...
February 1, 2023 By Durgasri Jaisankar, PhD, Postdoctoral Researcher at Brien Holden Vision Institute Recently, more studies have investigated the association between...